Table 1.
Characteristics of Patients undergoing Cancer Surgery (n=14,170)
| Characteristic | Value |
|---|---|
| Patient age, y, mean (SD) | 66.2 (11.0) |
| Male, n (%) | 7946 (56.1%) |
| Race, n (%) | |
| White | 10879 (76.8%) |
| Other | 1953 (13.8%) |
| African American | 1048 (7.4%) |
| Hispanic | 290 (2.1%) |
| Type of surgery, n (%) | |
| Pneumonectomy | 9255 (65.3%) |
| Pelvic exenteration | 2725 (19.2%) |
| Pancreatic resection | 1022 (7.2%) |
| Liver resection | 636 (4.5%) |
| Esophageal resection | 532 (3.8%) |
| Admit source, n (%) | |
| Outpatient | 13552 (95.6%) |
| Emergency room | 514 (3.6%) |
| Transfer | 104 (0.7%) |
| Discharge status, n (%) | |
| To home | 8405 (59.3%) |
| Transfer | 65 (0.5%) |
| SNF | 1214 (8.6%) |
| Home health care | 3786 (26.7%) |
| Dead | 398 (2.8%) |
| Hospice | 26 (0.2%) |
| Rehab | 212 (1.5%) |
| Other | 63 (0.4%) |
| Primary payer, n (%) | |
| Medicare | 8334 (58.8%) |
| Managed care | 3899 (27.5%) |
| Indemnity | 1081 (7.6%) |
| Medicaid | 538 (3.8%) |
| Uninsured | 203 (1.4%) |
| Other | 115 (0.8%) |
| DRG predicted mortality, n (%)* | |
| 1 | 5461 (38.5%) |
| 2 | 5843 (41.2%) |
| 3 | 2061 (14.5%) |
| 4 | 805 (5.7%) |
| Individual comorbidites, n (%) | |
| Hypertension | 7116 (50.2%) |
| Chronic pulmonary disease | 5696 (40.2%) |
| Metastatic cancer | 3366 (23.8%) |
| Diabetes | 2187 (15.4%) |
| Fluid and electrolyte disorders | 2138 (15.1%) |
| Deficiency anemia | 1587 (11.2%) |
| Hypothyroidism | 1100 (7.8%) |
| Peripheral vascular disease | 837 (5.9%) |
| Depression | 818 (5.8%) |
| Congestive heart failure | 713 (5.0%) |
| Obesity | 703 (5.0%) |
| Valvular disease | 624 (4.4%) |
| Solid tumor | 551 (3.9%) |
| Weight loss | 478 (3.4%) |
| Characteristics of hospitals Location, n (%) |
|
| Rural | 1042 (7.3%) |
| Urban | 13128 (92.7%) |
| No, of beds, n (%) | |
| 0–99 | 104 (0.7%) |
| 100–199 | 526 (3.7%) |
| 200–299 | 1666 (11.8%) |
| 300–399 | 2708 (19.1%) |
| 400–499 | 2140 (15.1%) |
| ≥ 500 | 7026 (49.6%) |
| Teaching hospital, n (%) | 5053 (35.7%) |
| Process measures, n (%) | |
| No prophylactic antibiotics on day of surgery | 1247 (8.8%) |
| Antibiotics continued inappropriately | 8797 (62.1%) |
| No beta-blockers in first 2 days after surgery | 2131 (15.0%) |
| No venous thromboembolism prevention in first 2 days | 10319 (72.8%) |
| No. of process measures missed | |
| 0 | 1255 (8.9%) |
| 1 | 4970 (35.1%) |
| 2 | 6416 (45.3%) |
| 3 or more | 1529 (10.8%) |
| Outcomes, n (%) | |
| Mortality up to 30 days | 427 (3.0%) |
| Readmission at 30 days | 1611 (11.4%) |
| Resource use | |
| Median length of stay, IQR | 8 (6,11) |
| Median total costs, IQR | 16529 (12335, 23640) |